Objective: This study was designed to examine the age and sex distribution and the effects of menopause in a large cohort of participants diagnosed with benign paroxysmal positional vertigo (BPPV).
T he peripheral vestibular organ consists of two accelerometers: the semicircular canals (SCCs) detecting angular velocity changes (ie, head turning) and the otolithic organs (utricle and saccule) measuring linear accelerations, including gravity (ie, accelerating in a car or tipping the head forward). In the otolithic organs, otoconia (composite crystals of CaCO 3 and proteins) serve as mass load. In benign paroxysmal positional vertigo (BPPV), according to the accepted theory, otoconia dislodge from the utricle and fall into the SCCs, thereby sensitizing them to gravity ( Fig.) . Head position changes (lying down, looking up, or turning over in bed) cause short, recurrent vertigo spells. Molecular causes of BPPV are currently unknown. Most BPPV cases seem to be idiopathic, although some others can be associated with head trauma, vestibular neuritis, or concurrent otologic diseases (chronic otitis, Meniere's disease, etc). Although clinicians have noted more frequent idiopathic cases in older persons (for a review, see Parnes et al 1 ) , few studies have investigated the effects of aging in a large cohort. Based on telephone interviews, Von Brevern et al 2 estimated the lifetime prevalence of BPPV to be 2.4% (with a sex predisposition toward women [prevalence, 3.2%] vs men [prevalence, 1.6%]), as well as the age dependence of BPPV, with prevalence steeply rising with age. Likewise, Mizukoshi et al 3 reported a higher female-tomale ratio for BPPV, with age at BPPV onset peaking in the fourth decade in both sexes. Oghalai et al 4 demonstrated the importance of aging in BPPV occurrence: 9% of a public inner-city geriatric population had unrecognized BPPV. These patients were more likely to have reduced activities and more likely to have sustained a fall in the previous 3 months, highlighting the negative impact of BPPV on daily living. The purpose of this study was to further explore the age and sex distribution and the effects of menopause in a large cohort of patients diagnosed with BPPV.
METHODS

Study design
We first reviewed anonymously the age and sex distribution of all patients diagnosed with BPPV at the Vestibular Clinic of the Boys Town National Research Hospital (BTNRH) between 2002 and 2011 (N = 1,377). A diagnosis of BPPV indicates the presence of nystagmus (rapid eye movements) elicited in either the Dix-Hallpike maneuver or the roll maneuver. Although a small subset of patients had subjective BPPV (when patients do not have positional nystagmus but subjectively report symptoms in response to the Dix-Hallpike maneuver, which has a short latency to onset and fatigue with no objective nystagmus), 5 we did not differentiate or exclude subtypes for the current study.
We directly surveyed female BPPV participants from this group using an anonymous questionnaire, which included current menopause status, past menstrual cycles and menopausal timing in relation to the onset of BPPV, use of hormone therapy (HT), and history of hysterectomy and oophorectomy. We used the commonly accepted definition of menopause, which is the absence of menses in the previous 12 months. Those diagnosed with other forms of vertigo, in addition to BPPV (based on medical records), were excluded from all studies in this report. Of the 935 female BPPV patients, 168 responded. Among the female survey participants, the ethnicity distribution was 79.9% Bnot Hispanic or not Latino[ and 20.1% BHispanic or Latino.[ The racial distribution was 96.3% white, 1.2% African American or black, 1.8% Asian, and 0.6% American Indian or Alaskan. Of the participants, 63.4% lived in urban and suburban areas, 33.5% lived in rural areas, and 3.1% were not sure. There were slightly lower percentages of minority races compared with those in Nebraska; however, given the predominance of whites in both populations (there were only one to three participants from minority races), such minority differences did not have a significant impact on conclusions.
BPPV patients from all four BTNRH clinics (one in east Omaha, one in west Omaha, and one each in two adjacent towns) were included. The size of the general population in the greater Omaha area comprises two thirds of the total population in Nebraska; therefore, the state's general population was used as the comparison group. With regard to oophorectomy (ovariectomy) and hysterectomy, US average statistics were used for comparison because data on the Nebraska population were not available. Such statistics are expected to be similar to those of Nebraska despite the higher percentages of whites (Hispanics/Latinos, blacks/African Americans, and Asians in Nebraska are about 60% to 40% of the US average) because no significant differences have been found between races in these categories. 6 All aspects of the study, including the content of the survey and the invitation letter, were reviewed and approved by the Institutional Review Board of the BTNRH in accordance with institutional, federal, and international guidelines.
Statistical analysis
The statistical significance of sex differences among BPPV cases per 100,000 Nebraska population in different age groups was evaluated by W 2 test with Yates correction, or by Fisher's exact test when the sample size was small.
RESULTS
Overall, BPPV prevalence greatly increased with age in both sexes when the age-related distribution of the Nebraska general population was considered (Table) . Across all ages, the femaleto-male ratio was 2.1:1 (female/male, 935:442), falling within the range of 1.5:1 to 2.2:1 in previous reports. 2,3,8<10 However, the number of BPPV cases relative to the Nebraska population distribution pointed to a high female-to-male ratio (3.2:1) in the age group 40 to 49 years. Interestingly, there was also a high female preponderance in BPPV in the age group 10 to 19 years, with a remarkable female-to-male ratio of 6.8:1 despite the small number of cases (Table) . An anonymous review of BPPV cases at the BTNRH from an earlier period (1998-2007) also showed similar high female-to-male ratios of 3.3:1 and 8.4:1, respectively, in these age groups.
A direct survey of the female BPPV patients (n = 168) showed that 48.1% experienced their first episodes of BPPV after menopause (14.7% of postmenopausal women aged 40-49 y), with only 9.0% of women on HT. Among the female survey participants, 22.4% had a oophorectomy (ovariectomy) and 32.0% had a hysterectomy. In the US general population, about 0.2% of women underwent oophorectomy and 0.5% of women underwent hysterectomy, 6 and about 40% of all postmenopausal women in the United States had ever used HT (nearly 50% of HT use based on the report by Brett and Chong, 11 with an approximately 20% decline in HT prescriptions since 2006; http://www.menopause.org/publications/clinical-practicematerials/Htstatistics/). For reasons stated in BMethods,[ the Nebraska general population probably have statistics similar to the US average, except for a possible higher percentage of HT use because non-Hispanic white women are more likely to use HT. 11 Compared with the entire BPPV population from the BTNRH, there were fewer participants among those 70 years or older but a similar distribution in other age groups, so the possible age bias does not affect the main conclusions.
DISCUSSION
BPPV is not only common but also incapacitating, especially in older persons. It can induce nausea, vomiting, fear, and balance dysfunction, which severely interferes with activities of daily living such as walking and driving, predisposing an individual to injury, hospitalization, and isolation. Our data show that age and sex are critical factors influencing BPPV onset, with an increase in prevalence with age in both sexes and a significant female preponderance. The even greater female-to-male ratios of BPPV cases in the age groups 10 to 19 and 40 to 49 years are novel findings and suggest that hormonal fluctuations, whether an increase or a decline, may influence BPPV occurrence.
In the US general population, the average age of menopause is 51 years 12, 13 and the average age of menarche is 12.5 years. 14 In women, estrogen and progesterone begin to decline before menopause and remain low after menopause, whereas folliclestimulating hormone increases and remains high. Perimenopausal fluctuations in estrogen levelsVnot just low estrogen levelsVmay account for the increased BPPV susceptibility of women aged 40 to 49 years. This is also reflected in the high rate of oophorectomy in the BPPV survey participants, who probably experienced sudden changes in hormone levels. Nevertheless, the higher BPPV prevalence in older women suggests that low estrogen levels do affect BPPV onset. In men, androgen (eg, testosterone) and estrogen also decline during this age period, but at a much slower rate. Although age effects on BPPV onset have been noted by previous reports, 9, 15 the differential effects of aging on different sexes have not been previously reported, nor has a detailed age and sex distribution of BPPV occurrence been reported.
Although formed at embryonic stages, mammalian otoconia seem to require proper maintenance during adult life because aging leads to otoconia degeneration in both humans 16<18 and animals. 19<21 As observed by these studies, age-related changes in the microenvironment and fragility of anchoring protein filaments (which keep otoconia adhered to the otolith organs) induce deterioration and dislocation. In addition, because Ca 2+ in otoconia is extruded by vestibular hair cells, 22 it is tempting to speculate that otoconia degeneration can also be associated with the hair cell loss seen in older persons. 23 Other types of age-related vestibular neurosensory degeneration can facilitate BPPV onset as well. 24 In addition, aging disrupts the homeostasis of endolymphatic ions and anions, 25 which would affect otoconia. Because a great majority (about Q90%) of recurring BPPV cases are unilateral 26 and because particle repositioning maneuvers (specific head maneuvers designed to return the dislocated otoconia from the SCCs back to the utricle) are largely effective in most cases, at least for a period, otoconiarelated abnormalities are more likely to be the primary cause.
Although the molecular events of aging that cause BPPV are unknown, in animal studies, numerous proteins important for otoconia formation and maintenance are no longer expressed or are only expressed at very low levels beyond early to middle adulthood, and estrogen deficiency exacerbates such problems (Xu, Yang, and Lundberg, unpublished data). Therefore, as part of the natural aging process, estrogen decline may cause otoconia degeneration and dislocation. Indeed, ovariectomy affects otoconia maintenance in rats 27 and mice (Yang, Xu, and Lundberg, unpublished data). Although Vibert et al 27 did not address whether otoconia in ovariectomized rats become dislocated more easily, an ongoing study in our laboratory shows that this is the case in ovariectomized mice (Yang, Xu, and Lundberg, unpublished data). Based on published information regarding the effects of estrogen and its receptors on the inner ear, mostly on the cochlea, estrogen may also influence endolymph ionic and anionic homeostases by regulating the expression of ion and anion channels and pumps. 28, 29 Endolymphatic ions and anions are known to influence otoconia/otolith formation in mice and fish (reviewed by Lundberg and Xu 30 ) and may be an additional mechanism underlying the influence of estrogen on otoconia maintenance and anchoring. It is possible that either a sudden drop or a sudden rise in estrogen would disrupt anion/ion homeostasis and affect neurosensory function, thereby contributing to the higher BPPV prevalence in older women and even young women entering puberty.
Although using only one BPPV population from a single hospital and its affiliated clinics has some advantages, such as uniform diagnostic criteria, it could have some potential limitations. For example, cases in the general population that are undiagnosed or simply not diagnosed in our hospital are not included. However, based on previous studies (references throughout the introduction and BResults[) and the location and specialty (primarily otolaryngology and pediatrics) of our hospital and clinics, the higher prevalence of BPPV in women and older people cannot be simply attributed to the fact that more women or older people see a doctor. Furthermore, the obtained prevalence is computed per 100,000 Nebraska population, and older men have higher prevalence when compared with the sex ratios of other age groups; thus, our overall conclusion is not probably a sampling bias.
CONCLUSIONS
Our data suggest important effects of age and sex on BPPV onset, which may be partly attributed to hormonal fluctuations. Based on otoconia studies in aging animals, we propose that otoconia degeneration, exacerbated by estrogen deficiency, may underlie such effects in older people and is an important area for further research.
